CVS Group plc
CVSGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $924 | $647 | $589 | $554 |
| % Growth | 42.8% | 9.9% | 6.3% | – |
| Cost of Goods Sold | $568 | $369 | $331 | $315 |
| Gross Profit | $357 | $278 | $258 | $239 |
| % Margin | 38.6% | 42.9% | 43.8% | 43.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $236 | $227 | $190 | $196 |
| SG&A Expenses | $236 | $227 | $190 | $196 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $22 | $0 | $0 | $0 |
| Operating Expenses | $258 | $227 | $190 | $196 |
| Operating Income | $99 | $51 | $68 | $43 |
| % Margin | 10.7% | 7.8% | 11.6% | 7.7% |
| Other Income/Exp. Net | -$54 | -$13 | -$8 | -$7 |
| Pre-Tax Income | $45 | $38 | $61 | $36 |
| Tax Expense | $19 | $12 | $12 | $10 |
| Net Income | $53 | $6 | $42 | $26 |
| % Margin | 5.7% | 1% | 7.1% | 4.6% |
| EPS | 0.37 | 0.087 | 0.59 | 0.36 |
| % Growth | 327.3% | -85.3% | 63.9% | – |
| EPS Diluted | 0.37 | 0.087 | 0.59 | 0.36 |
| Weighted Avg Shares Out | 72 | 72 | 71 | 71 |
| Weighted Avg Shares Out Dil | 72 | 72 | 72 | 72 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $24 | $13 | $8 | $7 |
| Depreciation & Amortization | $89 | $59 | $35 | $48 |
| EBITDA | $157 | $108 | $103 | $90 |
| % Margin | 17% | 16.7% | 17.5% | 16.2% |